Outbreak investigation of NDM-producing Burkholderia cepacia causing neonatal sepsis in Pakistan
dc.contributor.author | Batool, A | |
dc.contributor.author | Yakoob, A | |
dc.contributor.author | Anwar, Z | |
dc.contributor.author | Joshi, LT | |
dc.contributor.author | Lone, D | |
dc.contributor.author | Zikriya, M | |
dc.contributor.author | Ahmed, Q | |
dc.contributor.author | Qamar, MU | |
dc.date.accessioned | 2023-10-21T12:01:04Z | |
dc.date.available | 2023-10-21T12:01:04Z | |
dc.date.issued | 2023-10-18 | |
dc.identifier.issn | 1746-0921 | |
dc.identifier.issn | 1746-0921 | |
dc.identifier.uri | https://pearl.plymouth.ac.uk/handle/10026.1/21477 | |
dc.description.abstract |
Aim: To investigate the outbreak of Burkholderia cepacia complex (BCC), mortality, antimicrobial resistance and associated risk factors in the neonatal intensive care unit. Method: Eighteen blood culture samples from neonates and twenty swab samples from different neonatal intensive care unit surfaces were collected. The VITEK 2 was used to confirm the isolates and generate the antibiogram. PCR was used to identify blaNDM. Results: Eighteen samples tested positive for BCC, and 10/18 (55.5%) of the neonates died. 13/18 (72%) of the neonates had late-onset neonatal sepsis, and 10/18 (55%) had low birth weight. Resistance to minocycline and chloramphenicol was 100%, 72.2% to meropenem; 72.2% NDM gene was found in neonates and was 20% from the environment. Conclusion: Outbreak of NDM-producing BCC resulting in high neonatal mortality in NICU. | |
dc.format.extent | 1159-1169 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.publisher | Future Science Group | |
dc.subject | antimicrobial resistance | |
dc.subject | Burkholderia cepacia complex | |
dc.subject | NDM | |
dc.subject | neonatal septicemia | |
dc.title | Outbreak investigation of NDM-producing Burkholderia cepacia causing neonatal sepsis in Pakistan | |
dc.type | journal-article | |
dc.type | Article | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/37850347 | |
plymouth.issue | 16 | |
plymouth.volume | 18 | |
plymouth.publisher-url | http://dx.doi.org/10.2217/fmb-2023-0063 | |
plymouth.publication-status | Published online | |
plymouth.journal | Future Microbiology | |
dc.identifier.doi | 10.2217/fmb-2023-0063 | |
plymouth.organisational-group | |Plymouth | |
plymouth.organisational-group | |Plymouth|Faculty of Health | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|Users by role | |
plymouth.organisational-group | |Plymouth|Users by role|Academics | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine | |
plymouth.organisational-group | |Plymouth|Faculty of Health|Peninsula Dental School | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2023-08-03 | |
dc.date.updated | 2023-10-21T12:01:03Z | |
dc.rights.embargodate | 2024-10-17 | |
dc.identifier.eissn | 1746-0921 | |
dc.rights.embargoperiod | forever | |
rioxxterms.versionofrecord | 10.2217/fmb-2023-0063 |